» Articles » PMID: 9568995

Efficacies of Alkaline Protease, Elastase and Exotoxin A Toxoid Vaccines Against Gut-derived Pseudomonas Aeruginosa Sepsis in Mice

Overview
Journal J Med Microbiol
Specialty Microbiology
Date 1998 May 6
PMID 9568995
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

The protective efficacies of vaccines prepared from Pseudomonas aeruginosa alkaline protease, elastase and exotoxin A toxoids against gut-derived P. aeruginosa sepsis in mice were evaluated. Specific pathogen-free mice given P. aeruginosa strain D4 orally followed by cyclophosphamide (to promote translocation across the gut wall) died of bacteraemia. Mice immunised with one of the three individual toxoid vaccines were not significantly protected when compared to control mice immunised with bovine serum albumin. Combined immunisation with alkaline protease and elastase toxoids likewise showed no significant protective activity. However, combined immunisation with alkaline protease and exotoxin A toxoids significantly increased the survival rate, which reached 60% (compared with a 7.1% survival rate in the control group). These results show that alkaline protease and exotoxin A play important roles as pathogenic factors in gut-derived sepsis and that a combination of the two exoenzyme toxoids represents a logical candidate for vaccination against P. aeruginosa sepsis.

Citing Articles

Proteomic approach to identify host cell attachment proteins provides protective Pseudomonas aeruginosa vaccine antigen FtsZ.

Jurado-Martin I, Tomas-Cortazar J, Hou Y, Sainz-Mejias M, Mysior M, Sadones O NPJ Vaccines. 2024; 9(1):204.

PMID: 39468053 PMC: 11519640. DOI: 10.1038/s41541-024-00994-x.


Management of virulence in and using environmentally-friendly titanium dioxide nanoparticles.

Qais F, Altaf M, Ahmad I RSC Adv. 2023; 13(51):35841-35852.

PMID: 38090073 PMC: 10711673. DOI: 10.1039/d3ra06536g.


Virulence Factors of and Antivirulence Strategies to Combat Its Drug Resistance.

Liao C, Huang X, Wang Q, Yao D, Lu W Front Cell Infect Microbiol. 2022; 12:926758.

PMID: 35873152 PMC: 9299443. DOI: 10.3389/fcimb.2022.926758.


The Efficacy of Phage Therapy in a Murine Model of Pneumonia and Sepsis.

Yang X, Haque A, Matsuzaki S, Matsumoto T, Nakamura S Front Microbiol. 2021; 12:682255.

PMID: 34290683 PMC: 8287650. DOI: 10.3389/fmicb.2021.682255.


Understanding -Host Interactions: The Ongoing Quest for an Efficacious Vaccine.

Sainz-Mejias M, Jurado-Martin I, McClean S Cells. 2020; 9(12).

PMID: 33291484 PMC: 7762141. DOI: 10.3390/cells9122617.